A series of nicotinic ligands, carrying a quinoline nucleus, and characterized by a pharmacophoric distance between the quinoline nitrogen (H-bond acceptor) and the cationic nitrogen atoms higher than that proposed in the classical pharmacophoric models, have been synthesized and tested for their affinity for the central nicotinic receptor. The enantiomers of the nicotine analogue 1-methyl-2-pyrrolidinyl-6-quinoline and of its methiodide display enantioselectivity in binding studies, but not when tested in vivo; on α7* nicotinic receptor enantioselectivity is inverted with respect to the α4β2* subtype. N,N,N-Trimethyl-4-(quinolin-6- yl)but-3- yn-1-ammonium iodide (3c) and trans-N,N,N-trimethyl-4-(quinolin-6-yl)but-3-en-1- ammonium iodide (4c), showing pharmacophoric distances in the range 8.5-10.4 Å, interact with the α4β2* nicotinic receptor with Ki in the μM range; compound 3c shows preference for the α7* subtype.

Design, Synthesis, and Preliminary Pharmacological Evaluation of New Quinoline Derivatives as Nicotinic Ligands / L. GUANDALINI; M. NORCINI; K. VARANI; M. PISTOLOZZI; C. GOTTI; C. BAZZICALUPI; E. MARTINI; S. DEI; D. MANETTI; S. SCAPECCHI; E. TEODORI; C. BERTUCCI; C. GHELARDINI; M. N. ROMANELLI. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 50:(2007), pp. 4993-5002. [10.1021/jm070325r]

Design, Synthesis, and Preliminary Pharmacological Evaluation of New Quinoline Derivatives as Nicotinic Ligands

GUANDALINI, LUCA;NORCINI, MONICA;BAZZICALUPI, CARLA;MARTINI, ELISABETTA;DEI, SILVIA;MANETTI, DINA;SCAPECCHI, SERENA;TEODORI, ELISABETTA;GHELARDINI, CARLA;ROMANELLI, MARIA NOVELLA
2007

Abstract

A series of nicotinic ligands, carrying a quinoline nucleus, and characterized by a pharmacophoric distance between the quinoline nitrogen (H-bond acceptor) and the cationic nitrogen atoms higher than that proposed in the classical pharmacophoric models, have been synthesized and tested for their affinity for the central nicotinic receptor. The enantiomers of the nicotine analogue 1-methyl-2-pyrrolidinyl-6-quinoline and of its methiodide display enantioselectivity in binding studies, but not when tested in vivo; on α7* nicotinic receptor enantioselectivity is inverted with respect to the α4β2* subtype. N,N,N-Trimethyl-4-(quinolin-6- yl)but-3- yn-1-ammonium iodide (3c) and trans-N,N,N-trimethyl-4-(quinolin-6-yl)but-3-en-1- ammonium iodide (4c), showing pharmacophoric distances in the range 8.5-10.4 Å, interact with the α4β2* nicotinic receptor with Ki in the μM range; compound 3c shows preference for the α7* subtype.
2007
50
4993
5002
L. GUANDALINI; M. NORCINI; K. VARANI; M. PISTOLOZZI; C. GOTTI; C. BAZZICALUPI; E. MARTINI; S. DEI; D. MANETTI; S. SCAPECCHI; E. TEODORI; C. BERTUCCI...espandi
File in questo prodotto:
File Dimensione Formato  
NICOTINIC JMC 2007pdf.pdf

Accesso chiuso

Tipologia: Altro
Licenza: Tutti i diritti riservati
Dimensione 261.92 kB
Formato Adobe PDF
261.92 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/256072
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact